216867-60-6

Basic information

• Product Name: 6-(2-Methoxypyrimidin-5-yl)-nicotinic acid
• Synonyms: 6-(Pyridin-4-yl)-nicotinic acid;6-(Pyrimidin-5-yl)-nicotinic acid;6-(2-Methoxypyrimidin-5-yl)-nicotinic acid;[2,4-Bipyridine]-5-carboxylic acid
• CAS NO: 216867-60-6
• Molecular Formula: C11H9N3O3
• Molecular Weight: 200.19
• Mol File: 216867-60-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-(2-Methoxypyrimidin-5-yl)-nicotinic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(2-Methoxypyrimidin-5-yl)-nicotinic acid(216867-60-6)
• EPA Substance Registry System: 6-(2-Methoxypyrimidin-5-yl)-nicotinic acid(216867-60-6)

Safety Data

• Hazardous Substances Data: 216867-60-6(Hazardous Substances Data)

Upstream product

• 106047-21-6 5-methyl-2,4'-bipyridine 

Relevant articles and documents

Three unprecedented open frameworks based on a pyridyl-carboxylate: Synthesis, structures and properties

Three open frameworks, [Ni(pnta)2]·1.3DMF (1), [Zn 2(pnta)3(OH)]·2DMF (2), and [Cd(pnta) 2]·3.8DMF (3), were obtained by solvothermal reactions between 6-(pyridin-4-yl)nicotinic acid (Hpnta) and nickel(II), zinc(II) and cadmium(II) nitrate, respectively. Compound 1 is a chiral framework with a fourfold interpenetrated diamondoid network structure and two types of chiral channels. Compound 2 also possesses the fourfold interpenetrated adamantanoid architecture with helical rhombic nanotube-like channels, each of which has two sides of double-layer walls and two other sides of single-layer walls. Compound 3 is a rarely reported double-walled framework with bcu topology. The luminescent properties of compounds 2 and 3 have been studied in the solid state at room temperature.

Sulfonamide derivatives, their production and use

The present invention provides compounds which specifically inhibit FXa, which are effective when orally administered and which are useful as a safe medicine for the prevention or treatment of diseases caused by thrombus or infarction. Compounds of this invention are piperazinones of the formula: wherein R1is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; the ring A is an optionally substituted divalent nitrogen-containing heterocyclic group, in addition to being substituted by the group of the formula: and the group of the formula: Y is an optionally substituted divalent hydrocarbon group or an optionally substituted divalent heterocyclic group; X is a direct bond or an optionally substituted alkylene chain; Z is (1) an amino group substituted with an optionally substituted hydrocarbon group, (2) an optionally substituted imino group or (3) an optionally substituted nitrogen-containing heterocyclic group; provided that when X is a direct bond and Z is an optionally substituted 6-membered nitrogen-containing aromatic heterocyclic group, Y is an optionally substituted divalent hydrocarbon group or an optionally substituted divalent unsaturated heterocyclic group; or a salt thereof.